Paxlovid® (nirmatrelvir; ritonavir) – New drug approval
May 25, 2023 - The FDA announced the approval of Pfizer’s Paxlovid (nirmatrelvir; ritonavir), for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Top